<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d351" origId="Chloroprocaine"><sentence id="DrugDDI.d351.s0" origId="s0" text="The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension."><entity charOffset="22-38" id="DrugDDI.d351.s0.e0" origId="s0.p1" text="local anesthetic" type="drug"/><entity charOffset="60-71" id="DrugDDI.d351.s0.e1" origId="s0.p3" text="epinephrine" type="drug"/><entity charOffset="75-89" id="DrugDDI.d351.s0.e2" origId="s0.p5" text="norepinephrine" type="drug"/><entity charOffset="112-140" id="DrugDDI.d351.s0.e3" origId="s0.p8" text="monoamine oxidase inhibitors" type="drug"/><entity charOffset="142-167" id="DrugDDI.d351.s0.e4" origId="s0.p9" text="tricyclic antidepressants" type="drug"/><entity charOffset="171-185" id="DrugDDI.d351.s0.e5" origId="s0.p11" text="phenothiazines" type="drug"/><pair e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e1" id="DrugDDI.d351.s0.p0" interaction="false"/><pair e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e2" id="DrugDDI.d351.s0.p1" interaction="false"/><pair e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e3" id="DrugDDI.d351.s0.p2" interaction="true"/><pair e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e4" id="DrugDDI.d351.s0.p3" interaction="true"/><pair e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e5" id="DrugDDI.d351.s0.p4" interaction="true"/><pair e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e2" id="DrugDDI.d351.s0.p5" interaction="false"/><pair e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e3" id="DrugDDI.d351.s0.p6" interaction="true"/><pair e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e4" id="DrugDDI.d351.s0.p7" interaction="true"/><pair e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e5" id="DrugDDI.d351.s0.p8" interaction="true"/><pair e1="DrugDDI.d351.s0.e2" e2="DrugDDI.d351.s0.e3" id="DrugDDI.d351.s0.p9" interaction="false"/><pair e1="DrugDDI.d351.s0.e2" e2="DrugDDI.d351.s0.e4" id="DrugDDI.d351.s0.p10" interaction="false"/><pair e1="DrugDDI.d351.s0.e2" e2="DrugDDI.d351.s0.e5" id="DrugDDI.d351.s0.p11" interaction="false"/><pair e1="DrugDDI.d351.s0.e3" e2="DrugDDI.d351.s0.e4" id="DrugDDI.d351.s0.p12" interaction="false"/><pair e1="DrugDDI.d351.s0.e3" e2="DrugDDI.d351.s0.e5" id="DrugDDI.d351.s0.p13" interaction="false"/><pair e1="DrugDDI.d351.s0.e4" e2="DrugDDI.d351.s0.e5" id="DrugDDI.d351.s0.p14" interaction="false"/></sentence><sentence id="DrugDDI.d351.s1" origId="s1" text="Concurrent use of these agents should generally be avoided."/><sentence id="DrugDDI.d351.s2" origId="s2" text="In situations when concurrent therapy is necessary, careful patient monitoring is essential."/><sentence id="DrugDDI.d351.s3" origId="s3" text="Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents."><entity charOffset="29-46" id="DrugDDI.d351.s3.e0" origId="s3.p31" text="vasopressor drugs" type="drug"/><entity charOffset="125-139" id="DrugDDI.d351.s3.e1" origId="s3.p39" text="oxytocic drugs" type="drug"/><pair e1="DrugDDI.d351.s3.e0" e2="DrugDDI.d351.s3.e1" id="DrugDDI.d351.s3.p0" interaction="true"/></sentence><sentence id="DrugDDI.d351.s4" origId="s4" text="The para-aminobenzoic acid metabolite of chloroprocaine inhibits the action of sulfonamides."><entity charOffset="4-26" id="DrugDDI.d351.s4.e0" origId="s4.p45" text="para-aminobenzoic acid" type="drug"/><entity charOffset="41-55" id="DrugDDI.d351.s4.e1" origId="s4.p46" text="chloroprocaine" type="drug"/><entity charOffset="79-91" id="DrugDDI.d351.s4.e2" origId="s4.p49" text="sulfonamides" type="drug"/><pair e1="DrugDDI.d351.s4.e0" e2="DrugDDI.d351.s4.e1" id="DrugDDI.d351.s4.p0" interaction="false"/><pair e1="DrugDDI.d351.s4.e0" e2="DrugDDI.d351.s4.e2" id="DrugDDI.d351.s4.p1" interaction="false"/><pair e1="DrugDDI.d351.s4.e1" e2="DrugDDI.d351.s4.e2" id="DrugDDI.d351.s4.p2" interaction="true"/></sentence><sentence id="DrugDDI.d351.s5" origId="s5" text="Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed."><entity charOffset="11-25" id="DrugDDI.d351.s5.e0" origId="s5.p51" text="chloroprocaine" type="drug"/><entity charOffset="73-84" id="DrugDDI.d351.s5.e1" origId="s5.p58" text="sulfonamide" type="drug"/><pair e1="DrugDDI.d351.s5.e0" e2="DrugDDI.d351.s5.e1" id="DrugDDI.d351.s5.p0" interaction="true"/><negationtags>Therefore, chloroprocaine should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be used in any condition in which a sulfonamide drug is being employed&lt;/xcope&gt;.</negationtags></sentence></document>